Skip to main content
main-content

Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in diabetes

New additions to the Adis Journal Club – May update

Browse May's selection of peer-reviewed articles from the Adis journal portfolio. Curated by the editors and updated monthly. These papers highlight topical research and reviews for the benefit of Medicine Matters readers.

News

Study shows potential for type 2 diabetes characteristics to guide management

Research published in Nature Medicine shows how the specific characteristics of people with type 2 diabetes could one day guide disease management. Read more

Content hub

The challenge of type 2 diabetes in children

Who is at the highest risk for developing type 2 diabetes in their youth? What are the consequences of being diagnosed so young, and what can clinicians do to help? Browse the hub to find out

Content hub

Fasting for religion and health in people with diabetes

How can people with diabetes be supported during Ramadan? We examine the evidence and provide practical advice from experts on fasting with type 1 or type 2 diabetes. Browse the hub

Supporting people with diabetes during Ramadan

Evidence overview and practical advice for fasting with type 1 or type 2 diabetes

IN FOCUS | Obesity & lifestyle interventions

04-27-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

IN FOCUS | Pediatric type 2 diabetes

04-04-2022 | Dapagliflozin | News

Phase 3 trial supports dapagliflozin in young people with type 2 diabetes

The first phase 3 trial of an SGLT2 inhibitor in children and young people with type 2 diabetes shows that dapagliflozin significantly improves their glucose control – as long as they remember to take it.

The challenge of type 2 diabetes in children

Who is at the highest risk for developing type 2 diabetes in their youth? 

IN FOCUS | Hyperglycemia

04-14-2022 | Hyperglycemia | View from the clinic | Article

Managing hyperglycemia related to stress

Lori Berard highlights the contribution of stress to poor glycemic control and considers how healthcare providers can account for this in their practice.

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

IN FOCUS | Cardiovascular disorders

03-18-2022 | Cardiovascular outcomes | News

Weight gain and loss may both signal high cardiovascular risk in type 2 diabetes

The gain or loss of more than 5% bodyweight within a 2-year period is associated with an increased risk for major adverse cardiovascular events in people with type 2 diabetes, say researchers.

FEATURED WEB RESOURCE | Enter the Cushing’s Hub Competition

To celebrate the first anniversary of Cushing’s Hub, the Cushing’s Hub Editorial Board is pleased to announce the new Cushing’s Hub Competition in which clinicians are invited to submit ideas for clinical case learning modules, designed for healthcare professionals, on the subject of Cushing’s syndrome, hypercortisolemia and related clinical challenges. The winner will see their entry converted into an interactive educational format, with integrated vodcast, which will be promoted throughout Europe and beyond! Entrants can focus on any clinical aspect of the disease process, including complications, comorbidities, and quality of life. The competition opens on 28 February 2022 and runs through to 15 June 2022

To enter or for more information on the competition visit Cushing's Hub.

IN FOCUS | Hypoglycemia

03-31-2022 | Diet | Hot topic review | Article

Fasting and people with diabetes

Read this Hot Topic Review to catch up on the latest research into the risks and benefits of fasting for people with diabetes.

VIEW FROM THE CLINIC | Hypoglycemia

Hypoglycemia presentations that require deviation from standard management are rare, but challenging. To learn how to proceed in such cases, read this series by Sanjay Kalra, outlining these instances and offering pragmatic advice.

Read now

IN FOCUS | Tirzepatide

04-27-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

The SURPASS trials

Get the latest reporting, researcher interviews, and independent commentary on tirzepatide for type 2 diabetes.

IN FOCUS | Kidney disease

05-06-2022 | Nephropathy | News

Renal prognosis improvements stalled in type 1 diabetes

The risk for kidney disease has fallen for people diagnosed with type 1 diabetes in more recent decades, but is still substantial and has stopped decreasing, study results suggest.

IN FOCUS | SGLT2 inhibitors

04-04-2022 | Dapagliflozin | News

Phase 3 trial supports dapagliflozin in young people with type 2 diabetes

The first phase 3 trial of an SGLT2 inhibitor in children and young people with type 2 diabetes shows that dapagliflozin significantly improves their glucose control – as long as they remember to take it.

IN FOCUS | GLP-1 receptor agonists

02-07-2022 | Semaglutide | News

STEP 6: Semaglutide addresses ‘pathophysiology of metabolic syndrome’ in east Asians

The STEP 6 findings reveal significant weight loss, along with a reduction in abdominal visceral fat, in east Asian people with obesity taking a high dose of semaglutide.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Addressing suicide risk in diabetes

Learn about rates and risk, underlying psychological factors, and practical actions to support patients.

IN FOCUS | Mental health & psychosocial care

04-14-2022 | Hyperglycemia | View from the clinic | Article

Managing hyperglycemia related to stress

Lori Berard highlights the contribution of stress to poor glycemic control and considers how healthcare providers can account for this in their practice.

IN FOCUS | Diabetes devices & technology

04-27-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

Flash glucose monitoring technology

Browse new slide sets summarizing the latest results from real-world studies.

Podcasts

Interviews with experts on diabetes patient care